Experts to examine opportunities in growing African pharmaceutical market

12 March 2013

“At a time when growth in traditional pharmaceutical markets is stalling, strong macroeconomic fundamentals and rising health care expenditure across Africa presents considerable opportunities for health investment. Pharmaceutical companies are looking to expand into the region which offers a compelling opportunity and growth potential,” said Miles Mudzviti, managing director, United Communications & Media (Africa).

His comments were made in conjunction with the announcement of the inaugural Euro-Africa Health Investment Conference (EAHIC), which will gather industry executives, policy makers, investors, project developers and key stakeholders to identify and discuss the latest development opportunities in the African pharmaceutical sector, public-private cooperation, and pharmaceutical innovation to improve access to medicines and contribute to sustainable development of healthcare systems across Sub-Saharan Africa.

African pharma spending set to reach $30 billion by 2016

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >